Russ Reiss

Russ Reiss holds multiple key roles in the medical and biotech industries, serving as Scientific Advisor at Xenter and GlycoMira Therapeutics, Chief Operating Officer at StrongHolt Therapeutics and SymbioCellTech, and Cardiothoracic Surgeon at Parkview Medical Center and Timpanogos Regional Hospital. With expertise in translating innovative medical technologies into commercially viable products, Russ Reiss also founded Park City Performance Medicine and has extensive experience in product development at Transit Scientific. An accomplished academic, Reiss completed a Doctor of Medicine at Drexel University and has pursued advanced studies in gene therapy.